Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results